These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1605663

  • 1. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
    Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida O, Taguchi T, Kimura I.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):855-61. PubMed ID: 1605663
    [Abstract] [Full Text] [Related]

  • 2. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N.
    Cancer Res; 1991 Mar 01; 51(5):1472-7. PubMed ID: 1997185
    [Abstract] [Full Text] [Related]

  • 3. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
    Koyama H, Ogawa M, Kuraishi Y, Tominaga K, Yoshida M, Taguchi T.
    Gan To Kagaku Ryoho; 1992 Jul 01; 19(7):1049-53. PubMed ID: 1626940
    [Abstract] [Full Text] [Related]

  • 4. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
    Taguchi T, Wakui A, Nabeya K, Kurihara M, Isono K, Kakegawa T, Ota K.
    Gan To Kagaku Ryoho; 1992 Apr 01; 19(4):483-8. PubMed ID: 1558398
    [Abstract] [Full Text] [Related]

  • 5. [An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
    Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S, Ota K.
    Gan To Kagaku Ryoho; 1992 Jun 01; 19(6):863-9. PubMed ID: 1605664
    [Abstract] [Full Text] [Related]

  • 6. [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
    Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S, Ota K.
    Gan To Kagaku Ryoho; 1992 Jun 01; 19(6):871-7. PubMed ID: 1605665
    [Abstract] [Full Text] [Related]

  • 7. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
    Furuse K, Fukuoka M, Kurita Y, Ariyoshi Y, Niitani H, Yoneda S, Fujii M, Hasegawa K, Nishiwaki Y, Tamura M.
    Gan To Kagaku Ryoho; 1992 Jun 01; 19(6):879-84. PubMed ID: 1318698
    [Abstract] [Full Text] [Related]

  • 8. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K, Ikeda M, Yakushiji M, Nishimura H, Terashima Y, Sasaki H, Hata T, Kuramoto H, Tanaka K, Takahashi T.
    Gan To Kagaku Ryoho; 1992 Jun 01; 19(6):885-92. PubMed ID: 1605666
    [Abstract] [Full Text] [Related]

  • 9. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M, Miyake H, Ota K.
    Gan To Kagaku Ryoho; 1992 Aug 01; 19(9):1327-32. PubMed ID: 1503488
    [Abstract] [Full Text] [Related]

  • 10. Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
    Schilder RJ, LaCreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D.
    Cancer Res; 1994 Feb 01; 54(3):709-17. PubMed ID: 8306332
    [Abstract] [Full Text] [Related]

  • 11. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T, Mendelson D, Kurtin S, Richardson K, Von Hoff D, Hoos A.
    Cancer Chemother Pharmacol; 2006 Dec 01; 58(6):759-64. PubMed ID: 16847673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK.
    Clin Cancer Res; 1997 Mar 01; 3(3):373-9. PubMed ID: 9815694
    [Abstract] [Full Text] [Related]

  • 14. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Mar 01; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 15. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
    Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, Takeuchi S, Takamizawa H, Suzuki M, Arai M, Ota M.
    Gan To Kagaku Ryoho; 1992 May 01; 19(5):695-701. PubMed ID: 1580643
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A phase I study of DWA2114R].
    Ariyoshi Y, Wakui A, Hasegawa K, Niitani H, Ogawa M, Sakai Y, Majima H, Furue H, Miyake H, Taguchi T.
    Gan To Kagaku Ryoho; 1992 May 01; 19(5):685-93. PubMed ID: 1580642
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM, Caparros-Sison B, Allen JA, Walker R, Tan CT.
    Cancer Treat Rep; 1986 Jul 01; 70(7):865-9. PubMed ID: 3521846
    [Abstract] [Full Text] [Related]

  • 20. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
    Perez-Soler R, Lopez-Berestein G, Lautersztain J, al-Baker S, Francis K, Macias-Kiger D, Raber MN, Khokhar AR.
    Cancer Res; 1990 Jul 15; 50(14):4254-9. PubMed ID: 2364384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.